RBCC opens biotechnology headquarters in Houston
“We targeted Houston from the beginning due to its amazingly large and diverse medical research community based in the Texas Medical Center,” said RBCC CEO Patrick Brown. “The opportunities in Houston to develop new R&D partnerships and breakthroughs are unmatched anywhere else in the Southern U.S. We’re very excited to set up shop and forge ahead with our new biotech initiatives.”
With over $1.8 billion in annual academic research investments and over 160 life sciences companies, Houston attracts venture capitalists from across the nation to invest in the growing life sciences industry there.
“The city is the perfect incubator for a growing company like ours,” Brown said. “We look forward to developing new relationships with the researchers and investors who will help us develop the biotech solutions to a host of pressing wellness issues.”